Aly Karsan

Researcher
  • Canada's Michael Smith Genome Sciences Centre
  • University of British Columbia
Home > About Us > Our People > Researcher Bio
  • Bio

Related Research

  • Blood Cancers

    Uncovering the role of long noncoding RNAs in myeloid leukemia

    A 2022 Terry Fox New Investigator Award will help a BC scientist search for new therapeutic targets for leukemia in a poorly understood area of science: the non-coding regions of the genome. Dr. Ly Vu...

    Read More
  • Blood Cancers

    Exploiting pathogenic mechanisms in acute leukemia for clinical translation

    A longstanding Terry Fox-funded project on hard-to-treat leukemias has been renewed, and the new injection of funds – $6.3 million over five years – will help to furthe...

    Read More
  • Completed
    Blood Cancers

    Core pathogenic pathways in human leukemia

    Treatment for acute myeloid leukemia (AML), one of the most aggressive forms of leukemia, involves chemotherapy drugs that many patients find difficult to tolerate and long-term survival is low. New t...

    Read More

Related News & Events

  • Research Highlight|October 21, 2021

    RNA-seq is the best available tool to personalize treatment for patients with acute myeloid leukemia, study finds

    TFRI-funded researchers at BC Cancer in a new study demonstrate that a genomic test known as whole transcriptome sequencing (RNA-seq) is the best avai...

  • Research Highlight|December 14, 2020

    New study reveals why some patients with myelodysplastic syndrome become resistant to treatment

    BC-based researchers led by Drs. Aly Karsan and Sergio Martinez-Høyer have found that mutations in two genes – TP53 and RUNX1 – are responsible for dr...

  • Research Highlight|January 09, 2020

    Newly created synthetic cancer cells help advance understanding of leukemias

    For the first time ever, a team of TFRI-funded researchers has created synthetic cancer cells that are indistinguishable from T-cell acute lymphoblast...

  • Research Highlight|September 10, 2018

    Discovery of CD33 in human cord blood cells may affect design of targeted AML therapies

    This new discovery provides a possible explanation of why some trials that have used CD33 as a potential target for AML therapies have shown specific ...

  • Research Highlight|September 10, 2018

    New discovery answers long-held question about myelodysplastic syndromes

    In a study published in Nature Communications (June 2018), a team led by Dr. Aly Karsan (BC Cancer) suggests that the key to understanding how both bo...

  • Press Release|September 05, 2017

    Three 2017 PPG awards announced for cutting-edge projects in leukemia, oncolytic viruses, nanoparticle imaging

    The Terry Fox Research Institute has invested nearly $21.5-million to renew three 2017 Terry Fox New Frontiers Program Project Grants (PPGs).

  • All News & Events